Mitsu Chem Plast Limited reported that net profit in the fourth quarter of FY26 rose by 117.90 per cent to Rs 77.17 million (mn), while EBITDA increased by 72.98 per cent to Rs 142.27 mn, on a marginal decline in total income to Rs 867.95 mn, down 4.10 per cent year on year. The company said the EBITDA margin for the quarter improved to 16.45 per cent and net profit margin to 8.92 per cent, reflecting better operational efficiencies and a continuing shift towards higher value products. Earnings per share for the quarter were Rs five point six eight.

For the full year FY26 the company posted total income of Rs 3508.46 mn, an increase of 5.40 per cent, with EBITDA of Rs 346.63 mn and net profit of Rs 156.19 mn, up 48.88 per cent and 115.40 per cent respectively. Annual EBITDA margin rose to 9.90 per cent and net profit margin to 4.46 per cent. Earnings per share for FY26 stood at Rs 11.50, reflecting sustained profitability across segments and improved contribution from higher margin lines.

Operationally, Mitsu Chem Plast completed capacity expansion and commenced operations at the new Boisar facility in January 2026, adding approximately 900 tonnes (t) per annum and taking total installed capacity to more than 29,900 t per annum. The company entered a global supplier agreement with Arjohuntleigh Polska, which it said strengthens its presence in the healthcare vertical and expands export opportunities across more than 17 countries. The Furnastra healthcare furniture vertical continued to scale and the business broadened its product innovations for industrial packaging and hospital furniture components.

Management said disciplined execution, focus on higher value-added products and improved operating efficiencies were key drivers of the performance and described strategic entry into the Intermediate Bulk Container vertical as a natural extension of its packaging capabilities that will open a new avenue for growth. The company noted that forward-looking statements are subject to risks and uncertainties and that actual outcomes may differ, and it reaffirmed commitment to disciplined capital deployment and operational excellence.